You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Correspondence on ‘Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank’ by Raisi-Estabragh et al
  1. Oscar Jolobe
  1. British Medical Association, BMA House, London, UK
  1. Correspondence to Dr Oscar Jolobe, British Medical Assocation, BMA House, Tavistock Square, London, WC1H 9JP, UK; oscarjolobe{at}yahoo.co.uk

https://doi.org/10.1136/heartjnl-2022-322132

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    To the Editor No evaluation of cardiovascular disease and mortality sequelae of COVID-191 would be complete without documentation of the increase in the prevalence of mechanical complications (MCs) of myocardial infarction (MI) attributable to delay in seeking or obtaining timely reperfusion treatment for ST elevation myocardial infarction (STEMI). This delay was associated with a resurgence of STEMI-related MCs, namely, ventricular-free wall rupture, acute papillary muscle …

    View Full Text

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles